155 related articles for article (PubMed ID: 10208622)
1. Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients.
Calebotta A; Sáenz AM; González F; Carvalho M; Castillo R
Int J Dermatol; 1999 Mar; 38(3):217-21. PubMed ID: 10208622
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate is effective in the treatment of pemphigus vulgaris.
Enk AH; Knop J
Arch Dermatol; 1999 Jan; 135(1):54-6. PubMed ID: 9923781
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Snast I; Spitzer L; Hodak E; Levi A; Mimouni D; Leshem YA
Dermatology; 2021; 237(2):179-184. PubMed ID: 32756069
[TBL] [Abstract][Full Text] [Related]
5. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Lever WF; Schaumburg-Lever G
Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the adjuvant effect of tacrolimus in the management of pemphigus vulgaris: A randomized controlled trial.
Dastgheib L; Sadati MS; Baghernejhad M
J Dermatolog Treat; 2015 Feb; 26(1):90-3. PubMed ID: 24552352
[TBL] [Abstract][Full Text] [Related]
7. Short-Term Intravenous Infusion of Cyclophosphamide in the Treatment of Refractory Pemphigus Vulgaris: A Retrospective Study.
Zhang W; Wei S; Peng X; Xie S; Zhang Z; Zeng K; Lai K
Dermatology; 2021; 237(2):185-190. PubMed ID: 32814321
[TBL] [Abstract][Full Text] [Related]
8. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Smolle J
Hautarzt; 1985 Feb; 36(2):96-102. PubMed ID: 2985524
[TBL] [Abstract][Full Text] [Related]
10. [Pemphigus vulgaris and intraepithelial neoplasia localized to the vagina].
Hoareau F; Croue A; Marchetta J; Kettani S; Verret JL
Ann Dermatol Venereol; 2007; 134(6-7):564-6. PubMed ID: 17657185
[TBL] [Abstract][Full Text] [Related]
11. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
[TBL] [Abstract][Full Text] [Related]
12. Outcome of pemphigus vulgaris.
Kavusi S; Daneshpazhooh M; Farahani F; Abedini R; Lajevardi V; Chams-Davatchi C
J Eur Acad Dermatol Venereol; 2008 May; 22(5):580-4. PubMed ID: 18194237
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study.
Lapidoth M; David M; Ben-Amitai D; Katzenelson V; Lustig S; Sandbank M
J Am Acad Dermatol; 1994 May; 30(5 Pt 1):752-7. PubMed ID: 8176015
[TBL] [Abstract][Full Text] [Related]
14. The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
Lyakhovitsky A; Baum S; Scope A; Amichai B; Barzilai A; Rimer J; Trau H
Int J Dermatol; 2011 Aug; 50(8):1014-9. PubMed ID: 21781080
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
16. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
Mourellou O; Chaidemenos GC; Koussidou T; Kapetis E
Br J Dermatol; 1995 Jul; 133(1):83-7. PubMed ID: 7669646
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
Szép Z; Danilla T; Buchvald D
Cas Lek Cesk; 2005; 144(10):700-3. PubMed ID: 16279438
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Grundmann-Kollmann M; Korting HC; Behrens S; Kaskel P; Leiter U; Krähn G; Kerscher M; Peter RU
J Am Acad Dermatol; 1999 Jun; 40(6 Pt 1):957-60. PubMed ID: 10365927
[TBL] [Abstract][Full Text] [Related]
19. Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.
Beissert S; Mimouni D; Kanwar AJ; Solomons N; Kalia V; Anhalt GJ
J Invest Dermatol; 2010 Aug; 130(8):2041-8. PubMed ID: 20410913
[TBL] [Abstract][Full Text] [Related]
20. Long-term prognosis of pemphigus in Korea: retrospective analysis of 199 patients.
Kim MR; Kim HC; Kim SC
Dermatology; 2011; 223(2):182-8. PubMed ID: 22025028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
